Search filters

Filters
Clear All

Phase

  • 2
  • 2
  • 42
  • 46
  • 23
  • 1
  • 1
  • 44

Found 46 Rheumatoid Arthritis trials

A listing of Rheumatoid Arthritis medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

 XCI Maintenance in Scleroderma and Related Female-Biased Diseases
35-90 years
All genders
The research study is being done to understand both why and how scleroderma and related female-biased diseases affect women and men differently.  Though we do not know what causes these diseases, we do know that women are much more likely to develop them than men.  We are studying how the …
 Supplement Screening for Breast Cancer with Abbreviated MRI for Black Women with Increased Breast Density
40-75 years
Accepts healthy volunteer
Female
It is well known that black women develop breast cancers which present not only at an earlier age when breasts are denser, but also the cancers tend to be more aggressive subtypes than those found in Caucasian women of a similar age. In addition, the population-based breast cancer mortality for …
18-40 years
All genders
Adult healthy volunteers in the age group of 18-40 years, both male and female, and willing to participate in MRI at the University of Pennsylvania, department of  radiology facilitiesMild exercise  with calf muscle  briefly  is required, and MRI will be performed before and after exercise.
 Multiparametric MRI (mpMRI) for Preoperative Staging and Treatment Planning for Newly-Diagnosed Prostate Cancer
18-99 years
Male
Observational
This phase II trial studies how well multiparametric magnetic resonance imaging (MRI) works in evaluating cancer stage and helping treatment planning in patients with prostate cancer. Multiparametric MRI may be useful for evaluating the type of cancer in finding aggressive disease.
99 years and younger
All genders
Specific Aims include: Coordinate all human PET and MR imaging at U Penn, UCSF, Yale and WU. Standardize inclusion/exclusion criteria for patient groups - idiopathic PD, MSA, PSP, FTD and healthy controls. Harmonize PET scanning protocols and devices. Generate and coordinate all regulatory protocols including local Radiation Safety or Radioactive …
99 years and younger
All genders
Please see section 3 of the protocol "Objectives and Endpoints" The objectives and endpoints planned for this study are summarized in Table 3-1 for Part 1, and in Table 3-2 for Part 2 of the study. The objectives and endpoints planned for this study are summarized in Table 3-1 for …
 Mapping Muscle Specific Metabolism in Different Age Groups
18-80 years
Accepts healthy volunteer
All genders
The purpose of the study is to determine the changes in muscle metabolites by MRI before and after exercise.    The MRI will be performed while performing mild exercise of the calf muscle for 1-3 minutes.  We are actively recruiting adults between 18-30, 45-55 and 70-80.  Volunteers cannot have diabetes …
99 years and younger
All genders
Specific Aim 1: To image the intracranial artery vessel walls (brain), we will evaluate and compare scans acquired using standard-of-care T1 SPACE and T1 MPRAGE sequences with novel accelerated pulse sequences in patients with suspected intracranial vasculopathy. Specific Aim 2: To image the extracranial artery vessel walls (neck). We will …
 A Trial of Endocrine Response in Women with Invasive Lobular Breast Cancer
18-99 years
All genders
Phase 2
To study whether fulvestrant is more effective than anastrozole or tamoxifen in reducing Ki67 in ILC and whether that Ki67 reduction will correlate with alterations in expression of ER and ER-regulated genes. Differential Ki67 effect in this study will serve as a surrogate for outcome of ILC patients on endocrine …
 Combination Ipatasertib and Atezolizumab to Prevent Recurrence in Triple Negative Breast Cancer
18-99 years
All genders
Phase 2
The purpose of this study is to determine if a combination of two drugs, Ipatasertib and Atezolizumab, works as a treatment for residual cancer in breast or lymph nodes and have circulating tumor DNA in blood. Eligible subjects will be those with triple negative breast cancer.
1 - 10 of 46